Pronađeno: 1-5 / 5 radova

Autori: Ozelo M

>> Filter: Samo Article i Review

Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas  Janic Dragana M  Ozelo M  Santagostino E  Korsholm Lars  Matytsina Irina  Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter)
Autori Lentz SR  Cerqueira MH  Janic Dragana M  Kempton CL  Matytsina Irina  Misgav M  Oldenburg J  Ozelo M  Recht M  Rosholm A  Savic Aleksandar D  Suzuki Takashi  Tiede Andreas  Santagostino E 
Info HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program (Meeting Abstract)
Autori Mancuso ME  Ozelo M  Janic Dragana M  Matytsina Irina  Landorph Andrea  Zeuthan Niels  Roveda A  Pellegrino G 
Info HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 3, str. 65-66
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (Article)
Autori Kulkarni R  Karim Abdul F  Glamocanin S  Janic Dragana M  Vdovin V  Ozelo M  Rageliene L  Carboni E  Laguna P  Dobaczewski G  Seremetis S  Lindblom A  Santagostino E 
Info HAEMOPHILIA, (2013), vol. 19 br. 5, str. 698-705
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age (Meeting Abstract)
Autori Kulkarni R  Karim Abdul F  Glamocanin S  Janic Dragana M  Vdovin V  Ozelo M  Rageliene L  Carboni E  Laguna P  Dobaczewski G  Santagostino E 
Info HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-829
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX